Delivery Order SPE2DB24D8003-SPE2DB25FJTFM
Award Date
11/4/24
Potential Completion Date
11/5/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business. The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The total ceiling value of the contract is $3,984.67, with an ultimate completion date of August 20, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,806.85 contract is for the delivery of 90 units of the prescription drug Jardiance 25 mg tablets. The award is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical and medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,076.98, is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical's ECAT Generation V Program, which has...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 90 tablets of the pharmaceutical product Jardiance 10 mg. The contract has a ceiling value of $5,347.67 and a period of performance through November 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $27,657.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets over a performance period ending on November 20, 2024. The contract was not set aside for any specific business category. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This is a $9,135.66 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication, to support the DLA Troop Support Medical's medical supply chain operations. This delivery order is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $7,041.13, is for the delivery of the prescription medication Jardiance 25 mg tablets. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $16,111.10, is for the delivery of the pharmaceutical product Jardiance 25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of November 22, 2023. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA,...
This award is a Delivery Order contract valued at $3,052.83, issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication. This order is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...